Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates

Carrillo-Muñoz, Alfonso Javier; Tur-Tur, Cristina; Hernández-Molina, Juan M; Quindós, Guillermo; Marcos-Arias, Cristina; Eraso, Elena; Cárdenes, Delia; Ortiz-Maestro, Oscar; Santos, Patricia; Estivill, Dolors; Guardia, Celia; Giusiano, Gustavo.
Rev. esp. quimioter ; 23(3): 122-125, sept. 2010. tab
Artículo en Inglés | IBECS (España) | ID: ibc-81849

Documentos relacionados

  1. Virulence attributes and genetic variability of oral Candida albicans and Candida tropicalis isolates.
  2. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella.
  3. Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI-TOF MS identification.
  4. FTIR and Raman Spectroscopy-Based Biochemical Profiling Reflects Genomic Diversity of Clinical <i>Candida</i> Isolates That May Be Useful for Diagnosis and Targeted Therapy of Candidiasis.
  5. Altered phagocytosis and morphogenesis of phenotypic switching-derived strains of the pathogenic Candida tropicalis co-cultured with phagocytic cells.
  6. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
  7. Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality.
  8. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.
  9. We need to talk about Candida tropicalis: Virulence factors and survival mechanisms.
  10. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.